Correlating magnetic resonance findings with neuropathology and clinical signs in dogs and cats

Veterinary Radiology and Ultrasound

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Vite, Charles H ^a   Cross, Johnny R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apparent diffusion coefficient; Brain; Cat; Dog; Magnetization transfer ratio; MR imaging; Spectroscopy

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; METHODOLOGY; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING;

ANIMALS; CAT DISEASES; CATS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; DOG DISEASES; DOGS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NERVOUS SYSTEM DISEASES;

CANIS FAMILIARIS;

EID: 79952523115     PISSN: 10588183     EISSN: 17408261     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2010.01782.x     Document Type: Article

References (114)

1. van der Knaap MS, van der Grond J, Luyten PR, et al. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 1992;31:202-211.
2. Grossman RI, Hecht-Leavitt CM, Evans SM, et al. Experimental radiation injury: combined MR imaging and spectroscopy. Radiology 1988;169:305-309.
3. Kimotsuki T, Nagaoka T, Yasuda M, et al. Changes of magnetic resonance imaging on the brain in beagle dogs with aging. J Vet Med Sci 2005;67:961-967.
4. Carrera I, Dennis R, Mellor DJ, Penderis J, Sullivan M. Use of magnetic resonance imaging for morphometric analysis of the caudal cranial fossa in Cavalier King Charles Spaniels. Am J Vet Res 2009;70:340-345.
5. Rusbridge C. Chiari-like malformation with syringomyelia in the cavalier King Charles spaniel: long-term outcome after surgical management. Vet Surg 2007;36:396-405.
6. Cross HR, Cappello R, Rusbridge C. Comparison of cerebral cranium volumes between cavalier King Charles spaniels with Chiari-like malformation, small breed dogs and Labradors. J Small Anim Pract 2009;50:399-405.
7. Vernau KM, Kortz GD, Koblik PD, et al. Magnetic resonance imaging and computed tomography characteristics of intracranial intra-arachnoid cysts in 6 dogs. Vet Radiol Ultrasound 1997;38:171-176.
8. Kitagawa M, Kanayama K, Sakai T. Quadrigeminal cisterna arachnoid cyst diagnosed by MRI in five dogs. Aust Vet J 2003;81:340-343.
9. Matiasek LA, Platt SR, Shaw S, Dennis R. Clinical and magnetic resonance imaging characteristics of quadrigeminal cysts in dogs. J Vet Intern Med 2007;21:1021-1026.
10. Vullo T, Korenman E, Manzo RP, et al. Diagnosis of cerebral ventriculomegaly in normal adult beagles using quantitative MRI. Vet Radiol Ultrasound 1997;38:277-281.
11. Vite CH, Insko EK, Schotland HM, Panckeri K, Hendricks JC. Quantification of cerebral ventricular volume in English bulldogs. Vet Radiol Ultrasound 1997;38:437-443.
12. Vullo T, Korenman E, Manzo RP, et al. Diagnosis of cerebral ventriculomegaly in normal adult beagles using quantitative MRI. Vet Radiol Ultrasound 1997;38:277-281.
13. Henke D, Bottcher P, Doherr MG, Oechtering G, Flegel T. Computer-assisted magnetic resonance imaging brain morphometry in American Staffordshire Terriers with cerebellar cortical degeneration. J Vet Intern Med 2008;22:969-975.
14. Thames RA, Robertson ID, Flegel T, et al. Development of a morphometric magnetic resonance image parameter suitable for distinguishing between normal dogs and dogs with cerebellar atrophy. Vet Radiol Ultrasound 2010;51:246-253.
15. Young BD, Levine JM, Fosgate GT, et al. Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in Pug dogs. J Vet Intern Med 2009;23:527-535.
16. Cherubini GB, Platt SR, Anderson TJ, et al. Characteristics of magnetic resonance images of granulomatous meningoencephalomyelitis in 11 dogs. Vet Rec 2006;159:110-115.
17. Garosi L, McConnell JF, Platt SR, et al. Clinical and topographic magnetic resonance characteristics of suspected brain infarction in 40 dogs. J Vet Intern Med 2006;20:311-321.
18. McConnell JF, Garosi L, Platt SR. Magnetic resonance imaging findings of presumed cerebellar cerebrovascular accident in twelve dogs. Vet Radiol Ultrasound 2005;46:1-10.
19. Auriemma E, Barthez PY, van der Vlugt-Meijer RH, Voorhout G, Meij BP. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001-2003). J Am Vet Med Assoc 2009;235:409-414.
20. Kent MS, Bommarito D, Feldman E, Theon AP. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs. J Vet Intern Med 2007;21:1027-1033.
21. Westworth DR, Dickinson PJ, Vernau W, et al. Choroid plexus tumors in 56 dogs (1985-2007). J Vet Intern Med 2008;22:1157-1165.
22. Lipsitz D, Higgins RJ, Kortz GD, et al. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol 2003;40:659-669.
23. Troxel MT, Vite CH, Massicotte C, et al. Magnetic resonance imaging features of feline intracranial neoplasia: retrospective analysis of 46 cats. J Vet Intern Med 2004;18:176-189.
24. Polizopoulou ZS, Koutinas AF, Souftas VD, et al. Diagnostic correlation of CT-MRI and histopathology in 10 dogs with brain neoplasms. J Vet Med A Physiol Pathol Clin Med 2004;51:226-231.
25. Sturges BK, Dickinson PJ, Bollen AW, et al. Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med 2008;22:586-595.
26. Kraft SL, Gavin PR, DeHaan C, et al. Retrospective review of 50 canine intracranial tumors evaluated by magnetic resonance imaging. J Vet Intern Med 1997;11:218-225.
27. Cherubini GB, Mantis P, Martinez TA, Lamb CR, Cappello R. Utility of magnetic resonance imaging for distinguishing neoplastic from non-neoplastic brain lesions in dogs and cats. Vet Radiol Ultrasound 2005;46:384-387.
28. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte C. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med 2006;20:669-675.
29. Snyder JM, Lipitz L, Skorupski KA, Shofer FS, Van Winkle TJ. Secondary intracranial neoplasia in the dog: 177 cases (1986-2003). J Vet Intern Med 2008;22:172-177.
30. Troxel MT, Vite CH, Van Winkle TJ, et al. Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001). J Vet Intern Med 2003;17:850-859.
31. Summers BA, Cummings JF, de Lahunta A. Veterinary neuropathology. St. Louis: Mosby-Year Book, 1995.
32. Koestner A, Bilzer T, Schulman FY, Summers BA, Van Winkle TJ. Histological classification of tumors of the nervous system of domestic animals. Washington, DC: Armed Forces Institute of Pathology, 1999.
33. Cordy DR, Holliday TA. A necrotizing meningoencephalitis of pug dogs. Vet Pathol 1989;26:191-194.
34. Stalis IH, Chadwick B, Dayrell-Hart B, Summers BA, Van Winkle TJ. Necrotizing meningoencephalitis of Maltese dogs. Vet Pathol 1995;32:230-235.
35. Braund KG. Granulomatous meningoencephalomyelitis. J Am Vet Med Assoc 1985;186:138-141.
36. Wenger DA, Victoria T, Rafi MA, et al. Globoid cell leukodystrophy in cairn and West Highland white terriers. J Hered 1999;90:138-142.
37. Jortner BS, Jonas AM. The neuropathology of globoid-cell leucodystrophy in the dog. A report of two cases. Acta Neuropathol 1968;10:171-182.
38. Cervera V, Mai W, Vite CH, et al. Comparative magnetic resonance imaging findings between gliomas and presumed infarcts. Vet Radiol Ultrasound, doi: DOI: 10.1111/j.1740-8261.2010.01749.x.
39. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491.
40. Grossman RI. Application of magnetization transfer imaging to multiple sclerosis. Neurology 1999;53:S8-S11.
41. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. Am J Roentgenol 1992;159:591-599.
42. Davis D, Ulatowski J, Eleff S, et al. Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med 1994;31:454-460.
43. Dijkhuizen RM, de Graaf RA, Tulleken KA, Nicolay K. Changes in the diffusion of water and intracellular metabolites after excitotoxic injury and global ischemia in neonatal rat brain. J Cereb Blood Flow Metab 1999;19:341-349.
44. Lenkinski RE, Schnall MD MR spectroscopy and the biochemical basis of neurological disease. In: Atlas SW (ed): Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott-Raven, 1996;1619-1653.
45. Hajnal JV, Baudouin CJ, Oatridge A. Design and implementation of magnetization transfer pulse sequences for clinical use. J Comput Assist Tomogr 1992;16:7-18.
46. Cox IH, Roberts TPL, Moseley ME. Principles and techniques in neuroimaging. In: Kucharcyzk J, Moseley M, Barkovich AJ (eds): Magnetic resonance neuroimaging. Boca Raton: CRC Press, 1994;1-102.
47. Bagley LJ, Grossman RI, McGowan JC. Magnetization transfer contrast: its utility as a technique and its application to central nervous system pathology. Neurology 1999;53:S49-S51.
48. Runge VM, Wells JW, Williams NM, et al. Detectability of early brain meningitis with magnetic resonance imaging. Invest Radiol 1995;30:484-495.
49. Tofts P. Quantitative MRI of the brain: measuring changes caused by disease. Chichester: Wiley, 2003.
50. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-415.
51. Rademacher J, Engelbrecht V, Burgel U, Freund H, Zilles K. Measuring in vivo myelination of human white matter fiber tracts with magnetization transfer MR. Neuroimage 1999;9:393-406.
52. Wong KT, Grossman RI, Boorstein JM, Lexa FJ, McGowan JC. Magnetization transfer imaging of periventricular hyperintense white matter in the elderly. Am J Neuroradiol 1995;16:253-258.
53. McGowan JC, McCormack TM, Grossman RI, et al. Diffuse axonal pathology detected with magnetization transfer imaging following brain injury in the pig. Magn Reson Med 1999;41:727-733.
54. Lexa FJ, Grossman RI, Rosenquist AC. Dyke Award paper. MR of Wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation. Am J Neuroradiol 1994;15:201-212.
55. Hanyu H, Asano T, Sakurai H, et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J Neurol Sci 1999;167:37-44.
56. Lexa FJ, Grossman RI, Rosenquist AC. Detection of early axonal degeneration in the mammalian central nervous system by magnetization transfer techniques in magnetic resonance imaging. Ann N Y Acad Sci 1993;679:336-340.
57. Vite CH, McGowan JC, Braund KG, et al. Histopathology, electrodiagnostic testing, and magnetic resonance imaging show significant peripheral and central nervous system myelin abnormalities in the cat model of alpha-mannosidosis. J Neuropathol Exp Neurol 2001;60:817-828.
58. Vite CH, McGowan JC, Niogi SN, et al. Effective gene therapy for an inherited CNS disease in a large animal model. Ann Neurol 2005;57:355-364.
59. McGowan JC, Haskins M, Wenger DA, Vite C. Investigating demyelination in the brain in a canine model of globoid cell leukodystrophy (Krabbe disease) using magnetization transfer contrast: preliminary results. J Comput Assist Tomogr 2000;24:316-321.
60. Meyer JR, Androux RW, Salamon N, et al. Contrast-enhanced magnetization transfer MR of the brain: importance of precontrast images. Am J Neuroradiol 1997;18:1515-1521.
61. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330-346.
62. Grossman RI, Yousem DM. Neuroradiology: the requisites. St. Louis: Mosby, 1994.
63. Sotak CH. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int 2004;45:569-582.
64. Lutsep HL, Albers GW, DeCrespigny A, et al. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 1997;41:574-580.
65. Buckley DL, Bui JD, Phillips MI, et al. The effect of ouabain on water diffusion in the rat hippocampal slice measured by high resolution NMR imaging. Magn Reson Med 1999;41:137-142.
66. Zhong J, Petroff OA, Prichard JW, Gore JC. Changes in water diffusion and relaxation properties of rat cerebrum during status epilepticus. Magn Reson Med 1993;30:241-246.
67. Hasegawa Y, Formato JE, Latour LL, et al. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke 1996;27:1648-1655; discussion 1655-1646.
68. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082-1085.
69. Mechtler L. Neuroimaging in neuro-oncology. Neurol Clin 2009;27:171-201, ix.
70. Kang BT, Jang DP, Gu SH, et al. MRI features in a canine model of ischemic stroke: correlation between lesion volume and neurobehavioral status during the subacute stage. Comp Med 2009;59:459-464.
71. Shaibani A, Khawar S, Shin W, et al. First results in an MR imaging-compatible canine model of acute stroke. Am J Neuroradiol 2006;27:1788-1793.
72. Hasegawa D, Orima H, Fujita M, et al. Diffusion-weighted imaging in kainic acid-induced complex partial status epilepticus in dogs. Brain Res 2003;983:115-127.
73. Vite CH, Magnitsky S, Aleman D, et al. Apparent diffusion coefficient reveals gray and white matter disease, and T2 mapping detects white matter disease in the brain in feline alpha-mannosidosis. Am J Neuroradiol 2008;29:308-313.
74. Taylor WD, Payne ME, Krishnan KR, et al. Evidence of white matter tract disruption in MRI hyperintensities. Biol Psychiatry 2001;50:179-183.
75. Werring DJ, Brassat D, Droogan AG, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000;123:1667-1676.
76. Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626-1632.
77. Takahashi E, Dai G, Wang R, et al. Development of cerebral fiber pathways in cats revealed by diffusion spectrum imaging. Neuroimage 2010;49:1231-1240.
78. Zhao FY, Kuroiwa T, Miyasakai N, et al. Diffusion tensor feature in vasogenic brain edema in cats. Acta Neurochir 2006;96 (Suppl):168-170.
79. Takahashi E, Dai G, Rosen GD, et al. Developing neocortex organization and connectivity in cats revealed by direct correlation of diffusion tractography and histology. Cereb Cortex 2010, doi: DOI: 10.1093/cercor/bhq084.
80. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478-488.
81. Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders-biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001;186 (Suppl 1):S15-23.
82. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-325.
83. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 1994;35:606-613; discussion 613-604.
84. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458.
85. Barker PB, Gillard JH, van Zijl PC, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723-732.
86. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-463.
87. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994;193:465-472.
88. Tzika AA, Ball WS Jr, Vigneron DB, Dunn RS, Kirks DR. Clinical proton MR spectroscopy of neurodegenerative disease in childhood. Am J Neuroradiol 1993;14:1267-1281; discussion 1282-1264.
89. Grodd W, Krageloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990;336:437-438.
90. Krageloh-Mann I, Grodd W, Niemann G, Haas G, Ruitenbeek W. Assessment and therapy monitoring of Leigh disease by MRI and proton spectroscopy. Pediatr Neurol 1992;8:60-64.
91. Presant CA, Wolf W, Waluch V, et al. Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 1994;343:1184-1187.
92. Artemov D, Bhujwalla ZM, Maxwell RJ, et al. Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transfer. Magn Reson Med 1995;34:338-342.
93. He Q, Bhujwalla ZM, Maxwell RJ, Griffiths JR, Glickson JD. Proton NMR observation of the antineoplastic agent Iproplatin in vivo by selective multiple quantum coherence transfer (Sel-MQC). Magn Reson Med 1995;33:414-416.
94. Newell DR, Maxwell RJ, Golding BT. In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review. NMR Biomed 1992;5:273-278.
95. Magnitsky S, Vite CH, Delikatny EJ, et al. Magnetic resonance spectroscopy of the occipital cortex and the cerebellar vermis distinguishes individual cats affected with alpha-mannosidosis from normal cats. NMR Biomed 2010;23:74-79.
96. Johnston JB, Silva C, Hiebert T, et al. Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury. J Neurovirol 2002;8:420-431.
97. Podell M, Maruyama K, Smith M, et al. Frontal lobe neuronal injury correlates to altered function in FIV-infected cats. J Acquir Immune Defic Syndr 1999;22:10-18.
98. Power C, Moench T, Peeling J, Kong PA, Langelier T. Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 1997;77:1175-1185.
99. van der Toorn A, Verheul HB, Berkelbach van der Sprenkel JW, Tulleken CA, Nicolay K. Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy. Magn Reson Med 1994;32:685-691.
100. Krep H, Bottiger BW, Bock C, et al. Time course of circulatory and metabolic recovery of cat brain after cardiac arrest assessed by perfusion- and diffusion-weighted imaging and MR-spectroscopy. Resuscitation 2003;58:337-348.
101. Neppl R, Nguyen CM, Bowen W, et al. In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures. Am J Neuroradiol 2001;22:1933-1943.
102. Anderson JH, Strandberg JD, Wong DF, et al. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology. Invest Radiol 1994;29:597-605.
103. Nyberg SL, Cerra FB, Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998;4:158-165.
104. Barreiro CJ, Williams JA, Fitton TP, et al. Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg 2006;81:1593-1598.
105. Choe BY, Gil HJ, Suh TS, Shinn KS. Postmortem metabolic and morphologic alterations of the dog brain thalamus with use of in vivo 1H magnetic resonance spectroscopy and electron microscopy. Invest Radiol 1995;30:269-274.
106. Lewin R. Is your brain really necessary? Science 1980;210:1232-1234.
107. Thomas WB. Hydrocephalus in dogs and cats. Vet Clin North Am: Small Anim Pract 2010;40:143-149.
108. O'Hayon BB, Drake JM, Ossip MG, Tuli S, Clarke M. Frontal and occipital horn ratio: a linear estimate of ventricular size for multiple imaging modalities in pediatric hydrocephalus. Pediatr Neurosurg 1998;29:245-249.
109. Del Bigio MR, Crook CR, Buist R. Magnetic resonance imaging and behavioral analysis of immature rats with kaolin-induced hydrocephalus: pre- and postshunting observations. Exp Neurol 1997;148:256-264.
110. Fletcher JM, Bohan TP, Brandt ME, et al. Morphometric evaluation of the hydrocephalic brain: relationships with cognitive development. Childs Nerv Syst 1996;12:192-199.
111. Fletcher JM, McCauley SR, Brandt ME, et al. Regional brain tissue composition in children with hydrocephalus. Relationships with cognitive development. Arch Neurol 1996;53:549-557.
112. Shprecher D, Schwalb J, Kurlan R. Normal pressure hydrocephalus: diagnosis and treatment. Curr Neurol Neurosci Rep 2008;8:371-376.
113. Palm WM, Walchenbach R, Bruinsma B, et al. Intracranial compartment volumes in normal pressure hydrocephalus: volumetric assessment versus outcome. Am J Neuroradiol 2006;27:76-79.
114. Brochet B, Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 1999;53:S12-S17.